Novavax Stock Sinks as Revenue Misses Estimates in 'Transition Year'
Novavax posts a fourth-quarter loss of $1.44 a share on revenue of $291.3 million.
Stay updated with breaking news from John Jacobs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Novavax posts a fourth-quarter loss of $1.44 a share on revenue of $291.3 million.
NEW YORK, Feb 28 — Covid-19 vaccine maker Novavax today said it expects revenue this year to be flat or lower as it works to improve its commercial performance and pick up market...
(CTN News) - Novavax said Wednesday it still faces significant financial difficulties and expects its revenue to be flat or lower as it..............
Defence attorneys representing Oscar Barnes on Friday reiterated that there was “absolutely” no evidence presented in the trial connecting him to Tonia McDonald’s murder, while imploring the jury to return a not-guilty verdict. Attorney-at-law...
NEW YORK: Novavax has agreed to pay back international vaccine group Gavi at least $475 million in cash or vaccines...